Current trials
Card Grid - Our clinical trials
EN.10 tests de-escalated adjuvant treatment in patients with p53 wildtype/NSMP early-stage endometrial cancer.
A Phase III randomised clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer.
Researchers will use blood and tissue samples collected as part of the feMMe trial, to identify whether an endometrial cancer patient will or will not benefit from an LNG-IUD, in place of a hysterectomy.
This clinical trial will evaluate the effectiveness and safety of Dostarlimab, an immunotherapy drug for patients with early-stage endometrial cancer as an alternate, non surgical treatment option.
This trial compares groin ultrasound surveillance with groin node surgery in Queensland women with vulvar cancer, aiming to improve the patient recovery.
We aim to assess whether non-invasive groin ultrasound is a feasible and accurate method of predicting nodal involvement in vulvar cancer patients.
This clinical trial aims to determine if there is an association between participation in exercise and greater adherence to chemotherapy for ovarian cancer patients.
Evaluating the potential benefits of an individually tailored, exercise intervention during chemotherapy for recurrent ovarian cancer.
This study focuses on women at high risk of ovarian cancer and whether an alternative surgical approach is equivalent to the standard method in preventing ovarian cancer for women without the associated symptoms and risks.